You have 9 free searches left this month | for more free features.

pazopanib

Showing 1 - 25 of 147

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Advanced Cancers, Solid Tumors Trial in Houston (Pazopanib, Everolimus)

Active, not recruiting
  • Advanced Cancers
  • Solid Tumors
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Dec 16, 2022

Renal Cell Carcinoma, Ovarian Carcinoma, Thyroid Carcinoma Trial in Groningen (Olaparib, Lenvatinib, Sunitinib)

Not yet recruiting
  • Renal Cell Carcinoma
  • +4 more
  • Groningen, Netherlands
    University Medical Center Groningen
Jul 13, 2023

Refractory Solid Tumors Trial in Seoul (pazopanib)

Completed
  • Refractory Solid Tumors
  • pazopanib
  • Seoul, Korea, Republic of
    Samsung Medical Center
Jun 13, 2022

Hereditary Hemorrhagic Telangiectasia, Epistaxis, Anemia Trial (Pazopanib, Placebo oral capsule)

Not yet recruiting
  • Hereditary Hemorrhagic Telangiectasia
  • +4 more
  • Pazopanib
  • Placebo oral capsule
  • (no location specified)
Aug 17, 2022

Refractory Solid Tumors Trial in Seoul (pazopanib)

Completed
  • Refractory Solid Tumors
  • pazopanib
  • Seoul, Korea, Republic of
    Samsung Medical Center
Jun 13, 2022

Glioblastoma Multiforme Trial in Nice (Pazopanib)

Active, not recruiting
  • Glioblastoma Multiforme
  • Pazopanib
  • Nice, Cedex 2, France
    Centre Antoine Lacassagne
Mar 3, 2022

Advanced Soft-tissue Sarcoma, Metastatic Soft-tissue Sarcoma Trial in France (Pazopanib, HDM201)

Recruiting
  • Advanced Soft-tissue Sarcoma
  • Metastatic Soft-tissue Sarcoma
  • Bordeaux, France
  • +4 more
May 5, 2022

Solitary Fibrous Tumor, Extraskeletal Myxoid Chondrosarcoma Trial in Spain (Pazopanib)

Active, not recruiting
  • Solitary Fibrous Tumor
  • Extraskeletal Myxoid Chondrosarcoma
  • Pazopanib
  • Palma De Mallorca, Islas Baleares, Spain
  • +6 more
Jan 31, 2022

Advanced Cancers Trial in Houston (Crizotinib (Xalkori), Pazopanib, Pemetrexed)

Terminated
  • Advanced Cancers
  • Crizotinib (Xalkori)
  • +2 more
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Sep 3, 2021

Renal Cell Carcinoma Trial in Ireland, Sweden (Pazopanib)

Completed
  • Renal Cell Carcinoma
  • Pazopanib
  • Dublin, Leinster, Ireland
  • +8 more
Dec 22, 2021

Kidney Cancer Trial in Houston (Pazopanib, Temsirolimus, Quality of Life Assessment)

Completed
  • Kidney Cancer
  • Pazopanib
  • +3 more
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Aug 24, 2021

Locally Advanced Leiomyosarcoma, Metastatic Leiomyosarcoma, Stage III Uterine Corpus Leiomyosarcoma AJCC v8 Trial in New York

Recruiting
  • Locally Advanced Leiomyosarcoma
  • +5 more
  • New York, New York
    Columbia University/Herbert Irving Cancer Center
Jan 4, 2023

Ovarian Cancer, Fallopian Tube Cancer, Peritoneal Carcinoma Trial in United States (Pazopanib, Doxil)

Terminated
  • Ovarian Cancer
  • +2 more
  • Fort Myers, Florida
  • +3 more
Oct 4, 2021

Unspecified Adult Solid Tumor - Protocol Specific, Breast Cancer - Female Trial in New Brunswick (Pazopanib, Paclitaxel,

Active, not recruiting
  • Unspecified Adult Solid Tumor - Protocol Specific
  • Breast Cancer - Female
  • Pazopanib
  • +2 more
  • New Brunswick, New Jersey
    Rutgers Cancer Institute of New Jersey
Sep 20, 2021

Renal Cell Carcinoma, Clear-cell Metastatic Renal Cell Carcinoma Trial in Canada, United States (Nivolumab, Pazopanib,

Completed
  • Renal Cell Carcinoma
  • Clear-cell Metastatic Renal Cell Carcinoma
  • Nivolumab
  • +3 more
  • Duarte, California
  • +13 more
Nov 30, 2021

Adult Alveolar Soft Part Sarcoma, Adult Angiosarcoma, Adult Desmoplastic Small Round Cell Tumor Trial in Portland, Seattle

Completed
  • Adult Alveolar Soft Part Sarcoma
  • +18 more
  • Portland, Oregon
  • +1 more
Sep 23, 2021

Carcinoma, Renal Cell Trial in China, Korea, Republic of, Taiwan (Pazopanib, Sunitinib)

Completed
  • Carcinoma, Renal Cell
  • Guangzhou, Guangdong, China
  • +20 more
Dec 6, 2021

Sarcoma, Stomach Tumors, Tumors Trial run by the NCI (Pazopanib, ARQ 197)

Completed
  • Sarcoma
  • +2 more
  • Pazopanib
  • ARQ 197
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Jun 23, 2021

Germ Cell Tumors, Measurable Disease Trial in Milano (Pazopanib)

Completed
  • Germ Cell Tumors
  • Measurable Disease
  • Pazopanib
  • Milano, Mi, Italy
    Fondazione IRCCS Istituto Nazionale dei Tumori
May 12, 2021

Ovarian Cancer Trial in France (Pazopanib, Paclitaxel)

Completed
  • Ovarian Cancer
  • Avignon, France
  • +35 more
Feb 23, 2022

Osteosarcoma, Metastatic Osteosarcoma Trial in United States (pazopanib)

Terminated
  • Osteosarcoma
  • Metastatic Osteosarcoma
  • pazopanib
  • Duarte, California
  • +3 more
Apr 8, 2021

Acute Myeloid Leukemia Trial in Münster (Pazopanib)

Completed
  • Acute Myeloid Leukemia
  • Pazopanib
  • Münster, Germany
    Unviersity Hospital of Münster (UKM)
Apr 6, 2021

Locally Advanced Leiomyosarcoma, Metastatic Leiomyosarcoma, Stage III Uterine Corpus Leiomyosarcoma AJCC v8 Trial in New York

Not yet recruiting
  • Locally Advanced Leiomyosarcoma
  • +8 more
  • (no location specified)
Jul 6, 2022

Ovarian Tumors, Tumors, Ovarian, Ovarian Cancer Trial in United Kingdom (Pazopanib, Fosbretabulin)

Terminated
  • Ovarian Neoplasms
  • +2 more
  • Bath, United Kingdom
  • +9 more
May 13, 2021

Metastatic Renal Cell Cancer Trial in France (Pazopanib, Sunitinib)

Completed
  • Metastatic Renal Cell Cancer
  • Bordeaux, France
  • +7 more
Jan 11, 2021